Breast Augmentation Procedure Overview
Breast augmentation, also called augmentation mammoplasty, is a surgical procedure to increase breast size using implants or fat transfer. The American Society of Plastic Surgeons reports that breast augmentation has been the most performed cosmetic surgical procedure in the United States for multiple consecutive years, with over 300,000 surgeries performed annually in recent data. The procedure typically takes one to two hours and is performed under general anesthesia. Patients can choose between saline implants, silicone gel implants, or autologous fat grafting based on their anatomy and goals. Recovery time ranges from two to six weeks for most patients to return to normal activities. The FDA regulates breast implants as medical devices, requiring manufacturers to submit data on safety and performance before approval.
The two primary implant types approved by the FDA are saline-filled and silicone gel-filled implants. Saline implants are inserted empty and filled after placement, while silicone gel implants come pre-filled. Both types have a silicone outer shell. The FDA approved the first silicone gel breast implant in 1962. Modern implants include textured and smooth surface options, as well as round and shaped (teardrop) profiles. Implant sizes range from approximately 100cc to 800cc or more. The choice of implant depends on the patient's body type, desired outcome, and surgeon recommendation. The American Society of Plastic Surgeons provides patient education and procedure statistics to help individuals make informed decisions.
Costs, Financing, and Market Landscape
The average cost of breast augmentation in the United States was reported by the American Society of Plastic Surgeons as approximately $6,000 to $8,000 for surgeon fees alone in recent data, excluding anesthesia, operating room facilities, and other related expenses. Total out-of-pocket costs typically range from $8,000 to $12,000 depending on geographic location, implant type, and surgeon expertise. Most health insurance plans do not cover breast augmentation as it is considered elective cosmetic surgery. Patients often use medical financing plans, credit cards, or personal savings to cover the procedure. Forbes Advisor reports on medical loan options and patient financing trends for elective procedures.
The breast implant market is dominated by a small number of global manufacturers. The two primary companies in the U.S. market are Allergan, a subsidiary of AbbVie, and Mentor Worldwide, a subsidiary of Johnson & Johnson. These companies supply both saline and silicone gel implants to hospitals and private surgical practices. The global breast implants market was valued at approximately $2.5 billion in recent years and is projected to grow at a compound annual growth rate of around 4 to 5 percent through the next decade. Growth drivers include increasing demand for cosmetic procedures, rising disposable incomes in emerging markets, and advancements in implant technology. The U.S. Securities and Exchange Commission filings for AbbVie and Johnson & Johnson provide financial details on their medical device divisions.
Safety, Risks, and Regulatory Updates
Breast augmentation carries standard surgical risks including infection, bleeding, changes in nipple sensation, and capsular contracture, where scar tissue tightens around the implant. The FDA has identified Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) as a rare cancer risk associated with textured breast implants. In 2019, the FDA requested a voluntary recall of certain textured implants by Allergan due to a higher-than-expected rate of BIA-ALCL. Allergan subsequently removed its textured Biocell implants from the global market. The FDA continues to monitor long-term safety data and requires post-market surveillance